Targeting Dimethylarginine Dimethylaminohydrolases in Pulmonary Arterial Hypertension: A New Approach to Improve Vascular Dysfunction?

समान संसाधन

• Hepatic Dimethylarginine-Dimethylaminohydrolase1 is Reduced in Cirrhosis and is a Target for Therapy in Portal Hypertension
  द्वारा: Mookerjee, Rajeshwar P, और अन्य
  प्रकाशित: (2014)
• Overexpression of Dimethylarginine Dimethylaminohydrolase Protects against Cerebral Vascular Effects of Hyperhomocysteinemia
  द्वारा: Rodionov, Roman N., और अन्य
  प्रकाशित: (2009)
• Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
  द्वारा: Prisco, Sasha Z., और अन्य
  प्रकाशित: (2020)
• Effects of Dimethylarginine Dimethylaminohydrolase–1 Overexpression on the Response of the Pulmonary Vasculature to Hypoxia
  द्वारा: Bakr, Adel, और अन्य
  प्रकाशित: (2013)
• A single nucleotide polymorphism in the dimethylarginine dimethylaminohydrolase gene is associated with lower risk of pulmonary hypertension in bronchopulmonary dysplasia
  द्वारा: Trittmann, JK, और अन्य
  प्रकाशित: (2016)